| Name | Title | Contact Details |
|---|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals discovers, develops, and commercializes first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.
ENCOMPASS was established in 1985 as a wholly owned for profit subsidiary of the Iowa Foundation for Medical Care (IFMC). IFMC was established in 1972 through the cooperative efforts of business and physicians in response to increasing demands for
Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.
Join our #GetImmunityUpgraded 30-day Challenge to upgrade your immunity and help our brave nurses and doctors get equipment they need to protect us all!
Access Healthcare Services, Inc. is a Nepean, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.